Portfolio Design Labs LLC Purchases New Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Portfolio Design Labs LLC acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 9,928 shares of the pharmaceutical company’s stock, valued at approximately $4,040,000. Vertex Pharmaceuticals accounts for […]

Related Keywords

Canada ,Sanfordc Bernstein ,Robertw Baird ,Brucei Sachs , ,Royal Bank ,Needham Company ,Exchange Commission ,Jennison Associates ,Northern Trust Corp ,Insider Activity At Vertex Pharmaceuticals ,News Ratings For Vertex Pharmaceuticals Daily ,Norges Bank ,Securities Exchange Commission ,Portfolio Design Labs ,Barclays ,Quarter For Vertex Pharmaceuticals ,Vertex Pharmaceuticals Price Performance ,Vertex Pharmaceuticals ,Vertex Pharmaceuticals Incorporated ,Free Report ,Trust Corp ,Director Bruce ,Pharmaceuticals Incorporated ,Get Free Report ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,